Trade

with

Boston Scientific Inc
(NYSE: BSX)
AdChoices
13.02
+0.31
+2.44%
After Hours :
-
-
-

Open

12.75

Previous Close

12.71

Volume (Avg)

4.81M (11.83M)

Day's Range

12.71-13.02

52Wk Range

11.10-14.08

Market Cap.

16.85B

Dividend Rate ( Yield )

-

Beta

1.11

Shares Outstanding

1.33B

P/E Ratio (EPS)

70.92 (0.18)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 7.14B

    • Net Income

    • -121.00M

    • Market Cap.

    • 16.85B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 3.32

    • PEG (Price/Earnings Growth) Ratio

    • 11.04

    • Beta

    • 1.11

    • Forward P/E

    • 16.05

    • Price/Sales

    • 2.36

    • Price/Book Value

    • 2.57

    • Price/Cash flow

    • 15.87

      • EBITDA

      • 790.00M

      • Return on Capital %

      • 1.43

      • Return on Equity %

      • 3.65

      • Return on Assets %

      • 1.43

      • Book Value/Share

      • 4.94

      • Shares Outstanding

      • 1.33B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 14.50

        • Credit Rating

        • BBB-

        • Analysts

        • 8

        • EPS Estimate

        • 0.56

        • Cashflow Estimate

        • 1.07

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 3.50

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -96.90

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • -2.36

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 70.00

            • 64.08

            • Pre-Tax Margin

            • 0.84

            • 15.19

            • Net Profit Margin

            • 3.32

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 67.50

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -16.20

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -15.60

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.65

              • 0.34

              • Current Ratio

              • 1.81

              • 2.55

              • Quick Ratio

              • 0.93

              • 1.83

              • Interest Coverage

              • 1.20

              • 11.70

              • Leverage Ratio

              • 2.52

              • 1.86

              • Book Value/Share

              • 4.94

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 64.94

                • 34.48

                • P/E Ratio 5-Year High

                • 78.67

                • 224.03

                • P/E Ratio 5-Year Low

                • 26.76

                • 60.23

                • Price/Sales Ratio

                • 2.16

                • 3.20

                • Price/Book Value

                • 2.35

                • 3.23

                • Price/Cash Flow Ratio

                • 15.87

                • 18.66

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 3.65

                    (-11.90)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • 1.43

                    (-5.70)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • 4.03

                    (-9.90)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • 10.43k

                  • 34.11k

                  • Inventory Turnover

                  • 2.42

                  • 2.77

                  • Asset Turnover

                  • 0.43

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  120.00M
                  Operating Margin
                  1.68
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  15.87
                  Ownership

                  Institutional Ownership

                  93.51%

                  Top 10 Institutions

                  49.17%

                  Mutual Fund Ownership

                  58.34%

                  Float

                  85.53%

                  5% / Insider Ownership

                  0.69%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Health Care Fund

                  •  

                    42,743,200

                  • 16.19

                  • 3.23

                  • VA CollegeAmerica Growth Fund of America

                  •  

                    33,875,000

                  • -33.05

                  • 2.56

                  • Vanguard PrimeCap Fund

                  •  

                    28,342,560

                  • 0.00

                  • 2.14

                  • Dodge & Cox Stock Fund

                  •  

                    26,720,200

                  • -1.03

                  • 2.02

                  • Fidelity® Contrafund® Fund

                  •  

                    25,958,588

                  • 4.06

                  • 1.96

                  • Vanguard Mid-Cap Index Fund

                  •  

                    22,679,465

                  • 1.32

                  • 1.71

                  • Vanguard Total Stock Mkt Idx

                  •  

                    21,599,765

                  • 0.51

                  • 1.63

                  • VA CollegeAmerica Fundamental Investors

                  •  

                    20,000,000

                  • 9.10

                  • 1.51

                  • VA CollegeAmerica Cap World Gr and Inc

                  •  

                    18,208,800

                  • 0.00

                  • 1.37

                  • Fidelity® Select Health Care Portfolio

                  •  

                    17,000,000

                  • 12.07

                  • 1.28

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity Management and Research Company

                  •  

                    158,094,243

                  • -19.33%

                  • 11.94

                  • Vanguard Group, Inc.

                  •  

                    95,408,904

                  • +3.45%

                  • 7.21

                  • Capital Research Global Investors

                  •  

                    66,206,886

                  • -16.36%

                  • 5.00

                  • State Street Corp

                  •  

                    53,493,295

                  • +0.46%

                  • 4.04

                  • Wellington Management Company, LLP

                  •  

                    51,754,017

                  • +14.65%

                  • 3.91

                  • Capital World Investors

                  •  

                    49,803,632

                  • +114.26%

                  • 3.76

                  • PRIMECAP Management Company

                  •  

                    48,452,019

                  • -1.82%

                  • 3.66

                  • Dodge & Cox

                  •  

                    44,872,818

                  • -0.78%

                  • 3.39

                  • J.P. Morgan Investment Management Inc.

                  •  

                    41,854,749

                  • +954.99%

                  • 3.16

                  • BlackRock Fund Advisors

                  •  

                    41,053,784

                  • -1.18%

                  • 3.10

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Slow Growth

                  Style

                  Mid Core

                  Boston Scientific Inc is a developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. The Company’s products were offered for sale by seven core businesses - Interven...moretional Cardiology, Cardiac Rhythm Management (CRM), Endoscopy, Peripheral Interventions (PI), Urology and Women’s Health, Neuromodulation, and Electrophysiology (EP). market a broad portfolio of internally-developed and self-manufactured drug-eluting stents including the Promus® Element™ and Promus® Element™ Plus everolimus-eluting stents, as well as its TAXUS® Element™ and Ion™ paclitaxel-eluting stents. The Company sell various products designed to treat patients with peripheral disease (disease which appears in blood vessels other than in the heart and in the biliary...more tree), including a broad line of medical devices used in percutaneous transluminal angioplasty (PTA) and peripheral vascular stenting. Its peripheral product offerings include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters. Its peripheral angioplasty balloon technology includes its next-generation Mustang™ PTA balloon, its Coyote™ balloon catheter, a deliverable and ultra-low profile balloon dilatation catheter designed for a wide range of peripheral angioplasty procedures, and its Charger™ PTA Balloon Catheter, a 0.035” percutaneous transluminal angioplasty balloon catheter designed for post-stent dilatation as well as conventional balloon angioplasty to open blocked peripheral arteries. The Company also sell products designed to treat patients with non-vascular disease (disease that appears outside the blood system). Its non-vascular suite of products includes biliary stents, drainage catheters and micro-puncture sets designed to treat, diagnose and ease various forms of benign and malignant tumors. The Company continue to market its extensive line of Interventional Oncology product solutions, including the recently launched Renegade® HI-FLO™ Fathom® microcatheter and guidewire system and Interlock™ - 35 Fibered IDC™ Occlusion System for peripheral embolization. The Company develop, manufacture and market a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, including: Implantable cardioverter defibrillator (ICD), Implantable pacemaker systems. During 2013, the company marketed its products to over 13,000 hospitals, clinics, outpatient facilities and medical offices in approximately 100 countries. The Company is subject to various environmental laws, directives and regulations both in the U.S. and abroad. Its operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes.lessless

                  Key People

                  Mr. Michael F. Mahoney

                  CEO/Director/President

                  Pete M. Nicholas

                  Chairman of the Board/Co-Founder/Director

                  John E. Abele

                  Director Emeritus/Co-Founder

                  Mr. Daniel J. Brennan

                  CFO/Chief Accounting Officer/Executive VP

                  Kenneth J. Pucel

                  Executive VP, Divisional

                  • Boston Scientific Inc

                  • One Boston Scientific Place

                  • Natick, MA 01760-1537

                  • USA.Map

                  • Phone: +1 508 650-8000

                  • Fax: +1 508 647-2200

                  • bsci.com

                  Incorporated

                  1960

                  Employees

                  23,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: